Johnson & Johnson (J&J) reported third-quarter sales of contact lenses...

Johnson & Johnson (J&J) reported third-quarter sales of contact lenses and other related products of $800 million, up by 8.3 percent, or by 9.1 percent on an operational basis, versus the third quarter a year ago. Growth was partially driven by the performance of Oasys 1-Day and Oasys 1-Day for ...

To continue reading this article register now.

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Become a member today for full access from just €7,29 a week!

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation

Or sign-up for a trial month for just 9,90€. To continue reading this article register now.